Cannabis Breeding Tech Company Launches New Class of Genetics

Posted by Brian Sparks|February 11, 2021

Front Range Biosciences (FRB), a cannabis and hemp genetics platform company leveraging next generation breeding technology, has become one of the first genetics providers to launch a new product line of high THCv plant varieties in California, with availability in Colorado through licensed partners leveraging FRB’s technology platform. This first-generation product line is among the highest producers of THCv available, containing more than 20% total cannabinoids, more than 8% THCv, and more than 2% grassy and fruity terpenes. These new varieties yield twice the yield of typical THCv producing plants. THCv is rare and has been an elusive minor cannabinoid until now.

“FRB is continually developing new genetics to help growers, brands, and consumers find new applications for cannabis,” says Dr. Jonathan Vaught, CEO of Front Range Biosciences. “The cannabis market is evolving quickly, and consumers are constantly looking for new and unique experiences. We are leveraging genomics-driven breeding to rapidly develop new products for cannabis companies and brands, unlocking new product opportunities from the incredible diversity of chemistry this plant produces. THCv represents just one of many new products we are making more accessible to the supply chain from this versatile plant through breeding.

This is the first THCv product line from FRB’s breeding program and expansive cannabis genetics library. This revolutionary THCv variety will pave the way for more unique consumer products, medical research, and therapeutics. There is also a growing body of research linking THCv to a number of potential therapeutic benefits, including regulating tremors and seizures in ALS and Parkinson’s patients, blocking fight or flight responses in PTSD, and acting as an effective analgesic for treating pain and migraines.

“THCv, along with other minor cannabinoids, terpenes, and even flavonoids, have been a challenging group of traits for breeders to develop while maintaining the level of vigor and yield needed to introduce these products into the supply chain effectively,” says Dr. Reggie Gaudino, VP of R&D for Front Range Biosciences. “The many years of genomics and chemistry research our team has been committed to for cannabis is allowing us to help growers and product companies do so much more with the plant than what was possible, even just a few years ago.”

Learn more here.